News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
726,513 Results
Type
Article (42073)
Company Profile (285)
Press Release (684145)
Multimedia
Podcasts (83)
Webinars (17)
Section
Business (205840)
Career Advice (2041)
Deals (35691)
Drug Delivery (112)
Drug Development (81690)
Employer Resources (173)
FDA (16442)
Job Trends (14993)
News (348026)
Policy (32851)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2625)
Accelerated approval (32)
Adcomms (24)
Allergies (142)
Alliances (50097)
ALS (172)
Alzheimer's disease (1675)
Antibody-drug conjugate (ADC) (312)
Approvals (16712)
Artificial intelligence (522)
Autoimmune disease (154)
Automation (39)
Bankruptcy (363)
Best Places to Work (11675)
BIOSECURE Act (21)
Biosimilars (190)
Biotechnology (188)
Bladder cancer (157)
Brain cancer (58)
Breast cancer (643)
Cancer (4831)
Cardiovascular disease (399)
Career advice (1723)
Career pathing (36)
CAR-T (285)
CDC (44)
Celiac Disease (2)
Cell therapy (749)
Cervical cancer (36)
Clinical research (69762)
Collaboration (1715)
Company closure (4)
Compensation (1159)
Complete response letters (54)
COVID-19 (2731)
CRISPR (93)
C-suite (853)
Cystic fibrosis (144)
Data (6233)
Decentralized trials (2)
Denatured (27)
Depression (134)
Diabetes (501)
Diagnostics (6777)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (256)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (231)
Earnings (90329)
Editorial (58)
Employer branding (21)
Employer resources (152)
Events (117921)
Executive appointments (978)
FDA (19563)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1474)
Gene editing (205)
Generative AI (44)
Gene therapy (605)
GLP-1 (976)
Government (4682)
Grass and pollen (6)
Guidances (383)
Healthcare (18968)
HIV (59)
Huntington's disease (45)
IgA nephropathy (83)
Immunology and inflammation (251)
Immuno-oncology (58)
Indications (111)
Infectious disease (3000)
Inflammatory bowel disease (188)
Inflation Reduction Act (14)
Influenza (116)
Intellectual property (249)
Interviews (317)
IPO (16711)
IRA (50)
Job creations (3659)
Job search strategy (1442)
JPM (57)
Kidney cancer (16)
Labor market (85)
Layoffs (553)
Leadership (31)
Legal (7969)
Liver cancer (92)
Longevity (14)
Lung cancer (653)
Lymphoma (376)
Machine learning (43)
Management (59)
Manufacturing (795)
MASH (163)
Medical device (13856)
Medtech (13909)
Mergers & acquisitions (20051)
Metabolic disorders (1272)
Multiple sclerosis (160)
NASH (16)
Neurodegenerative disease (317)
Neuropsychiatric disorders (89)
Neuroscience (2910)
Neurotech (1)
NextGen: Class of 2026 (6567)
Non-profit (4545)
Now hiring (67)
Obesity (597)
Opinion (264)
Ovarian cancer (166)
Pain (200)
Pancreatic cancer (229)
Parkinson's disease (279)
Partnered (33)
Patents (497)
Patient recruitment (491)
Peanut (56)
People (59282)
Pharmaceutical (64)
Pharmacy benefit managers (29)
Phase 1 (21789)
Phase 2 (30711)
Phase 3 (22862)
Pipeline (5281)
Policy (282)
Postmarket research (2566)
Preclinical (9251)
Press Release (65)
Prostate cancer (237)
Psychedelics (48)
Radiopharmaceuticals (279)
Rare diseases (842)
Real estate (5991)
Recruiting (70)
Regulatory (24579)
Reports (52)
Research institute (2442)
Resumes & cover letters (355)
Rett syndrome (27)
RNA editing (17)
RSV (77)
Schizophrenia (150)
Series A (241)
Series B (191)
Service/supplier (11)
Sickle cell disease (100)
Special edition (21)
Spinal muscular atrophy (157)
Sponsored (42)
Startups (3657)
State (2)
Stomach cancer (17)
Supply chain (104)
Tariffs (84)
The Weekly (54)
Vaccines (1008)
Venture capital (89)
Weight loss (384)
Women's health (91)
Worklife (18)
Date
Last 7 days (615)
Last 30 days (2072)
Last 365 days (29919)
2026 (3446)
2025 (30339)
2024 (35409)
2023 (40283)
2022 (51397)
2021 (55955)
2020 (54332)
2019 (46804)
2018 (35244)
2017 (32377)
2016 (31774)
2015 (37825)
2014 (31526)
2013 (26590)
2012 (28789)
2011 (29426)
2010 (27538)
Location
Africa (749)
Alabama (83)
Alaska (7)
Arizona (310)
Arkansas (13)
Asia (39705)
Australia (6472)
California (11334)
Canada (3289)
China (1106)
Colorado (479)
Connecticut (483)
Delaware (337)
Europe (85568)
Florida (1689)
Georgia (355)
Hawaii (3)
Idaho (61)
Illinois (863)
India (65)
Indiana (519)
Iowa (23)
Japan (432)
Kansas (127)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1393)
Massachusetts (8145)
Michigan (324)
Minnesota (630)
Mississippi (5)
Missouri (129)
Montana (32)
Nebraska (28)
Nevada (122)
New Hampshire (79)
New Jersey (3004)
New Mexico (28)
New York (2985)
North Carolina (1469)
North Dakota (10)
Northern California (5527)
Ohio (335)
Oklahoma (21)
Oregon (41)
Pennsylvania (2278)
Puerto Rico (24)
Rhode Island (48)
South America (1117)
South Carolina (66)
South Dakota (1)
Southern California (4412)
Tennessee (176)
Texas (1751)
United States (40189)
Utah (335)
Vermont (1)
Virginia (262)
Washington D.C. (81)
Washington State (921)
West Virginia (4)
Wisconsin (109)
Wyoming (2)
726,513 Results for "c2i genomics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Veracyte Completes Acquisition of C2i Genomics
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced it has completed its acquisition of C2i Genomics, Inc., adding whole-genome minimal residual disease (MRD) capabilities to its novel diagnostics platform.
February 6, 2024
·
5 min read
Press Releases
Bionano Genomics, Inc. Announces Closing of $10 Million Public Offering
September 18, 2025
·
6 min read
Press Releases
Bionano Genomics, Inc. Announces Pricing of $10 Million Public Offering
September 17, 2025
·
7 min read
Business
Veracyte Announces Preliminary Full-Year 2023 Results, Acquisition of C2i Genomics to Add Minimal Residual Disease Capabilities to Its Novel Diagnostics Platform
Veracyte Announces Preliminary Full-Year 2023 Results, Acquisition of C2i Genomics to Add Minimal Residual Disease Capabilities to Its Novel Diagnostics Platform.
January 8, 2024
·
9 min read
Press Releases
One Genomics and CiRA Foundation Announce Strategic Research Collaboration to Advance Precision Genome Engineering
January 9, 2026
·
2 min read
Press Releases
Fox Chase Cancer Center and Arima Genomics Partner to Advance 3D Genome Diagnostics for Cancer Care
January 8, 2026
·
5 min read
Press Releases
PacBio Joins iHope Initiative as First Long-Read Genomic Sequencing Partner
February 12, 2026
·
6 min read
Press Releases
10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026
February 12, 2026
·
11 min read
Press Releases
GeneDx Announces GenomeDx Prenatal™, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care
January 8, 2026
·
7 min read
Press Releases
Targeted Genomics Launches Celiac Genetic Testing Services for Texas Physicians
February 2, 2026
·
2 min read
1 of 72,652
Next
